Net sales and profits grew year-over-year, driven by aggressive store expansion and cost controls amid inflation and geopolitical risks. The outlook for FY2027 anticipates continued sales growth but a slight decline in net profit, with a higher annual dividend planned.Original document: COSMOS Phar…
Net sales and profits grew year-over-year, driven by aggressive store expansion and cost controls amid inflation and geopolitical risks. The outlook for FY2027 anticipates continued sales growth but a slight decline in net profit, with a higher annual dividend planned.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.